Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

HAE Haemonetics Corp

68,30

0,83 (1,23%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:01:08

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Haemonetics (NYSE:HAE)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Haemonetics Charts.

Haemonetics (NYSE:HAE)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Haemonetics Charts.

News Haemonetics Corp

Form 8-K - Current report
Montag 3 März 2025 (1 Woche vor) • Edgar (US Regulatory)

Haemonetics Announces Executive Leadership Updates
Montag 3 März 2025 (1 Woche vor) • PR Newswire (US)

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
Montag 24 Februar 2025 (2 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 6 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 6 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Donnerstag 6 Februar 2025 (1 Monat vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 14 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
Dienstag 14 Januar 2025 (2 Monate vor) • PR Newswire (US)

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Mittwoch 8 Januar 2025 (2 Monate vor) • PR Newswire (US)

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Freitag 3 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 3 Dezember 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Haemonetics Corp News-Artikel

Financial Select Sector

Invesco QQQ Trust Series 1

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen